MedPath

Vitamin D3

Generic Name
Vitamin D3
Brand Names
Adrovance, Animi-3 With Vitamin D, Citranatal B-calm Kit, Citranatal Harmony, Fosamax Plus D, Fosavance, Infuvite, Infuvite Pediatric, Mvc-fluoride, Natafort, Pregvit, Vidextra
Drug Type
Small Molecule
Chemical Formula
C27H44O
CAS Number
67-97-0
Unique Ingredient Identifier
1C6V77QF41

Overview

Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake . Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 . Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use . Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism . However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency .

Background

Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake . Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 . Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use . Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism . However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency .

Indication

Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia . Concurrently, as one of the most commonly utilized forms of vitamin D, cholecalciferol is also very frequently used as a supplement in individuals to maintain sufficient vitamin d levels in the body or to treat vitamin D deficiency, as well as various medical conditions that can be associated directly or indirectly with vitamin d insufficiency like osteoporosis and chronic kidney disease, among others .

Associated Conditions

  • Bone Fractures
  • Calcium and Vitamin D Deficiencies
  • Deficiency of Vitamin D3
  • Deficiency, Vitamin A
  • Deficiency, Vitamin D
  • Hip Fracture
  • Hypoparathyroidism
  • Hypophosphatemia, Familial
  • Menopause
  • Osteomalacia
  • Osteoporosis
  • Postmenopausal Osteoporosis
  • Vertebral Fractures
  • Vitamin D Resistant Rickets
  • Vitamin Deficiency
  • Severe Bone Resorption
  • Spine fracture

FDA Approved Products

CitraNatal Harmony
Manufacturer:MISSION PHARMACAL COMPANY
Route:ORAL
Strength:400 [iU] in 1 1
Approved: 2010/05/03
NDC:0178-0812
Quflora Pediatric
Manufacturer:CarWin Pharmaceutical Associates, LLC
Route:ORAL
Strength:400 [iU] in 1 1
Approved: 2024/01/10
NDC:15370-104
Prenate Pixie
Manufacturer:Avion Pharmaceuticals, LLC
Route:ORAL
Strength:500 [iU] in 1 1
Approved: 2021/01/07
NDC:75854-316
PRENATE Restore
Manufacturer:Avion Pharmaceuticals, LLC
Route:ORAL
Strength:1000 [iU] in 1 1
Approved: 2021/01/07
NDC:75854-308
Animi-3 with Vitamin D
Manufacturer:PBM Pharmaceuticals, Inc
Route:ORAL
Strength:1000 [iU] in 1 1
Approved: 2011/05/23
NDC:66213-542

Singapore Approved Products

Fosamax Plus™ 70mg/2800IU Tablet
Manufacturer:Rovi Pharma Industrial Services S.A., Merck Sharp & Dohme B.V. (Primary and Secondary Packager)
Form:TABLET
Strength:2800 iu
Online:Yes
Approved: 2005/10/31
Approval:SIN13152P
D-CURE ORAL SOLUTION 25000IU
Manufacturer:SMB Technology S.A.
Form:SOLUTION
Strength:25000IU
Online:Yes
Approved: 2017/06/05
Approval:SIN15254P
CERNEVIT FOR INJECTION
Manufacturer:FAREVA PAU 1 (Sub-contractor), Baxter S.A.
Form:INJECTION, POWDER, FOR SOLUTION
Strength:220 iu/vial
Online:Yes
Approved: 2002/06/05
Approval:SIN11975P
GP CHOLECALCIFEROL SOFTGEL CAPSULE 25,000 IU
Manufacturer:XL LABORATORIES PRIVATE LIMITED
Form:CAPSULE, LIQUID FILLED
Strength:25,000IU
Online:Yes
Approved: 2025/01/27
Approval:SIN17171P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath